Company Filing History:
Years Active: 2024
Title: Mengya Ma: Innovator in Kappa Opioid Receptor Antagonism
Introduction
Mengya Ma is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmacology, particularly in the development of kappa opioid receptor antagonists. His innovative work has led to the creation of a unique crystalline salt form that holds promise for various therapeutic applications.
Latest Patents
Mengya Ma holds a patent for a solid Form A of 1-(6-ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)piperidin-4-amine hydrochloride. This compound exhibits specific X-ray diffraction patterns, making it a valuable antagonist of the kappa-opioid receptor (KOR). The patent outlines its potential use in treating conditions that can benefit from KOR antagonism.
Career Highlights
Mengya Ma is currently associated with Neumora Therapeutics, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on improving therapeutic outcomes for patients.
Collaborations
Mengya has collaborated with esteemed colleagues such as Brian Van Dyke and Yawei Shi. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Mengya Ma's contributions to the field of pharmacology, particularly through his patent on kappa opioid receptor antagonists, highlight his role as an influential inventor. His ongoing work at Neumora Therapeutics, Inc. continues to pave the way for advancements in medical treatments.